ইঙ্গিত
Bicalutamide is indicated, in combination with a luteinizing hormone-releasing hormone (LHRH) analogue, for the treatment of Stage D2 metastatic carcinoma of the prostate.
⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।
ফার্মাকোলজি
Bicalutamide belongs to a class of medicines called non-steroidal androgen receptor inhibitors. It works by attaching to androgen receptors within the target tissue, thereby blocking the action of androgens (male hormones) at those sites. Prostate cancer is generally androgen-sensitive, meaning it tends to respond to treatments that either counteract the effect of androgens or reduce the amount of androgen available in the body.
Pregnancy & Breastfeeding
Bicalutamide should never be used during pregnancy, as it may harm the developing baby. It is not intended for use in women at all, and no human studies exist on its use during pregnancy.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
ডোজ নির্দেশিকা
⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।